Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local anaesthetic inhibition of bradykinin and substance P flare responses
2004-000333-10Phase 4Completed
- Sponsor
- University of Dundee
- Start
- Feb 2005
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine, levobupivacaine and ropivacaine (3 arms), sponsored by University of Dundee. Primary endpoints: Cutaneous blood flow response to intradermal bradykinin and Cutaneous blood flow response to intradermal substance P. Started Feb 2005; status: completed.
02
Drugs
lidocainelevobupivacaineropivacaine
Beyond the preview
Go deeper on 2004-000333-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000333-10.